Relationships Among the EmPHasis-10 Questionnaire, the Simplified Four-Strata Risk Assessment Tool, and Echocardiographic Parameters in Patients with Precapillary Pulmonary Hypertension
Authors:
- Andreea VargaAndreea Varga
- Liviu CristescuLCLiviu Cristescu
- Dragos-Gabriel IancuDragos-Gabriel Iancu
- Robert-Adrian DumbravaRDRobert-Adrian Dumbrava
- Diana-Andreea MoldovanDMDiana-Andreea Moldovan
- Florin StoicaFSFlorin Stoica
- Stefania Raluca FodorSFStefania Raluca Fodor
- Claudiu NeaguCNClaudiu Neagu
- Radu Adrian SuteuRSRadu Adrian Suteu
- Ioan TileaIoan Tilea
Open Access
- 11 November 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6782
Abstract
Background/Objectives: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are complex diseases that require precise diagnosis and management. The ESC risk score has been used in both conditions. We assessed the relationship between the EmPHasis-10 questionnaire (patient subjective evaluation) and objective assessment using endorsed tools (simplified four-strata risk assessment and right ventricular imaging by transthoracic echocardiography). Methods: The present study retrospectively extracted data from 40 adult patients (27 PAH and 13 CTEPH cases) diagnosed in a single center in Romania. The EmPHasis-10 questionnaire and the four-strata risk assessment (FSRA) tool were applied to each patient. Mean pulmonary artery pressure (mPAP), tricuspid annular plane systolic excursion (TAPSE), TAPSE/systolic pulmonary artery pressure (TAPSE/sPAP) ratio, and right ventricular outflow tract acceleration time (RVOT-AT) were assessed. Results: A significant correlation was observed between the EmPHasis-10 scores and the FSRA tool, the WHO functional class, and the 6 min walking distance. Emphasis-10 score did not correlate with any of the echocardiographic parameters. The FSRA tool showed a moderate positive correlation with mPAP (r = 0.42, p = 0.01) and a negative correlation with TAPSE (r = −0.46, p = 0.003); additionally, across the entire cohort, it was moderately negatively correlated with both RVOT-AT (r = −0.42, p = 0.01) and TAPSE/sPAP ratio (r = −0.43, p = 0.005). Conclusions: Our study evidenced the alignment between EmPHasis-10 scores and prognostic risk score, with poorer health-related quality of life corresponding to higher FSRA. The EmPHasis-10 questionnaire proves to be a valuable, easy-to-use instrument, offering meaningful insights into patients’ health-related quality of life, underscoring its utility in enhancing comprehensive patient assessment and management.Keywords
Funding Information
- “George Emil Palade” University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Romania (615/13/17)
This publication has 38 references indexed in Scilit:
- Severity of functional tricuspid regurgitation is associated with mortality in patients with pulmonary hypertension in long‐term follow‐upPulmonary Circulation, 2023
- The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohortAutoimmunity Reviews, 2023
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Journal of Heart Failure, 2022
- Quality of Life is Related to Haemodynamics in Precapillary Pulmonary HypertensionHeart, Lung and Circulation, 2020
- Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide ConcentrationsEuropean Journal of Heart Failure, 2019
- Assessment of pulmonary artery pressure by echocardiography—A comprehensive reviewIJC Heart & Vasculature, 2016
- Prognostic value of right ventricular free wall strain in pulmonary hypertension patients with pseudo-normalized tricuspid annular plane systolic excursion valuesThe International Journal of Cardiovascular Imaging, 2016
- Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension?JACC, 2012
- Diagnosis and differential assessment of pulmonary arterial hypertensionJACC, 2004
- Primary pulmonary hypertensionProgress in Cardiovascular Diseases, 1988